Investigation Overview
November 09, 2015 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of MedAssets, Inc. (NASDAQ:MDAS), was announced concerning whether the takeover of MedAssets, Inc. by Pamplona Capital Management for $31.25 per share is unfair to NASDAQ:MDAS stockholders.
The investigation by a law firm concerns whether certain officers and directors of MedAssets, Inc. breached their fiduciary duties owed to NASDAQ:MDAS investors in connection with the proposed acquisition.
On November 2, 2015 MedAssets, Inc. (NASDAQ:MDAS) and Pamplona Capital Management announced that they have entered into an agreement whereby Pamplona will acquire MedAssets, Inc. (NASDAQ:MDAS) for $31.35 per share in cash.
However, the investigation concerns whether the offer is unfair to NASDAQ:MDAS stockholders. More specifically, the investigation concerns whether the MedAssets Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.